HAUPPAUGE, N.Y.--(BUSINESS WIRE)--May 17, 2007--Medical Action
Industries Inc. (NASDAQ: MDCI), announced today that it will hold a
conference call to present financial results for the quarter and year
ended March 31, 2007 on Thursday, May 31, 2007 at 4:30 p.m. (ET).
Paul D. Meringolo, Medical Action's President and CEO further
advised that our results of operations for the quarter and year ended
March 31, 2007 are scheduled to be released on Thursday, May 31, 2007
before the market opens. A conference call will be conducted by Mr.
Meringolo and Richard G. Satin, Vice President of Operations and
General Counsel, to discuss Medical Action's financial results.
The conference call will be simultaneously webcast on our web
site: www.medical-action.com. The dial-in number for the conference
call is 1-888-858-4756 (domestic) or 1-973-582-2824 (international);
conference ID #8769024. The complete call and discussion will be
available for replay on our website beginning at 6:30 p.m. (ET) on May
31, 2007.
Medical Action is a diversified manufacturer of disposable medical
devices. Its products are marketed primarily to acute care facilities
in domestic and certain international markets. Further, Medical Action
has expanded its target market to include physician, dental and
veterinary office, out-patient surgery centers and long-term
facilities. Medical Action is a leading manufacturer and distributor
of many of its products in the markets we compete in. Our products are
marketed through an extensive network of direct sales personnel and
independent distributors. Medical Action has preferred vendor
agreements with national distributors, as well as contracts with
nearly every major group purchasing alliance. The Company's common
stock trades on the NASDAQ Global Select Market under the symbol MDCI
and is included in the Russell 2000 Index.
This news release contains forward-looking statements that involve
risks and uncertainties regarding Medical Action's operations and
future results. Please see the Company's filings with the Securities
and Exchange Commission, including, without limitation, the Company's
Form 10-K and Form 10-Qs, which identify specific factors that would
cause actual results or events to differ materially from those
described in the forward-looking statements.
CONTACT: Medical Action Industries Inc.
Richard G. Satin, 631-231-4600
Vice President Operations and General Counsel
SOURCE: Medical Action Industries Inc.